These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
38 related articles for article (PubMed ID: 10220597)
1. Would a national pharmaceutical strategy be bad for the cardiovascular health of Canadians? Tu JV Can J Cardiol; 2007 Jul; 23(9):719-20. PubMed ID: 17622394 [No Abstract] [Full Text] [Related]
2. Medication adherence: a call for action. Bosworth HB; Granger BB; Mendys P; Brindis R; Burkholder R; Czajkowski SM; Daniel JG; Ekman I; Ho M; Johnson M; Kimmel SE; Liu LZ; Musaus J; Shrank WH; Whalley Buono E; Weiss K; Granger CB Am Heart J; 2011 Sep; 162(3):412-24. PubMed ID: 21884856 [TBL] [Abstract][Full Text] [Related]
3. Novel cardiovascular therapeutics and the risk of financial toxicity. Gunn AH; Pendyal A Nat Rev Cardiol; 2024 Jun; 21(6):349-350. PubMed ID: 38485769 [No Abstract] [Full Text] [Related]
4. Health-related quality of life in emphysema. Kaplan RM; Ries AL Proc Am Thorac Soc; 2008 May; 5(4):561-6. PubMed ID: 18453372 [TBL] [Abstract][Full Text] [Related]
5. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluating the economic implications of cardiovascular therapeutics. Califf RM Am Heart J; 1999 May; 137(5):S35-7. PubMed ID: 10220593 [No Abstract] [Full Text] [Related]
6. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Statistical issues in cost-effectiveness analysis. DeLong ER; Simons T Am Heart J; 1999 May; 137(5):S47-50. PubMed ID: 10220596 [No Abstract] [Full Text] [Related]
7. Proceedings of a symposium: economics and cost-effectiveness in evaluating the value of cardiovascular therapies. What constitutes a useful health economic study for the pharmaceutical industry? Gagnon JP Am Heart J; 1999 May; 137(5):S62-6. PubMed ID: 10220599 [No Abstract] [Full Text] [Related]
8. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. A survey of standards and guidelines for cost-effectiveness analysis in health care. Stewart A; Schmier JK; Luce BR Am Heart J; 1999 May; 137(5):S53-61. PubMed ID: 10220598 [No Abstract] [Full Text] [Related]
9. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Terminology I would like to see disappear. Detsky AS Am Heart J; 1999 May; 137(5):S51-2. PubMed ID: 10220597 [No Abstract] [Full Text] [Related]
10. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Role of economic models in randomized clinical trials. Hlatky MA Am Heart J; 1999 May; 137(5):S41-6. PubMed ID: 10220595 [No Abstract] [Full Text] [Related]
11. The cost effectiveness of cardiovascular medicines. Hay J Curr Atheroscler Rep; 2005 Mar; 7(2):79-80. PubMed ID: 15727719 [No Abstract] [Full Text] [Related]